Диссертация (1174352), страница 20
Текст из файла (страница 20)
Scand. - 2003. - Vol. 108(2). P. 109-113.205. Pojoga L, Gautier S, Blanc H, Guyene TT, Poirier O, Cambien F, BenetosA. Genetic determination of plasma aldosterone levels in essential hypertension // Am JHypertens. - 1998. - Vol. 11(7). - P. 856-60.118119206. Prisco D., Chiarantini E., Boddi M. et al.
Predictive value for thromboticdisease of plasminogen activator inhibitor-1 plasma levels // Int. J. Clin. Lab. Res. 1993. - Vol. 23(2). - P. 78-82.207.Psaty B.M., Smith N.L., Siscovick D.S. et al. Health outcomes associatedwith antihypertensive therapies used as first-line agents. A systematic review andmetaanalysis // JAMA. - 1997. - Vol. 277(9). - P. 739 -745.208. Reiner A.P., Siscovick D.S., Rosendaal F.R. Platelet glycoprotein genepolymorphisms and risk of thrombosis: facts and fancies // Rev. Clin. Exp. Hematol.
2001. - Vol. 5(3). - P. 262-287.209.Rigat B., Hubert C., Alhenc-Gelas F. et al. An insertion/deletionpolymorphism in the angiotensin I-converting enzyme gene accounting for half thevariance of serum enzyme levels // J. Clin. Invest. - 1990. - Vol. 86(4). - P. 1343-1346.210. Roest M., van der Schouw Y.T., Banga J.D. et al. Plasminogen activatorinhibitor 4G polymorphism is associated with decreased risk of cerebrovascularmortality in older women // Circulation. - 2000.
- Vol. 101(1). - P. 67-70.211. Rosand J., Bayley N., Rost N., de Bakker P.I. Many hypotheses but noreplication for the association between PDE4D and stroke // Nat. Genet. - 2006. - Vol.38(10). - P. 1091-1092.212. Rubattu S., Di Angelantonio E., Nitsch D. et al. Polymorphisms inprothrombotic genes and their impact on ischemic stroke in a Sardinian population //Thromb"Haemost. - 2005. - Vol. 93(6). - P. 1095-1100.213.
Rubin LL, Ransohoff RM. Treatment with BBB022A or rolipram stabilizesthe blood-brain barrier in experimental autoimmune encephalomyelitis: an additionalmechanism for the therapeutic effect of type IV phosphodiesterase inhibitors // JNeuroimmunol. - 1999. - Vol. 97(1-2). - P. 119-28.214. Paolucci S. et al. Post-stroke depression, antidepressant treatment andrehabilitation results. A case-control study // Cerebrovasc Dis.
- 2001. - Vol. 12. - P.264-371.215. SaleheenD.,BukhariS.,HaiderS.R.etal.Associationofphosphodiesterase 4D gene with ischemic stroke in a Pakistani population // Stroke. 2005. - Vol. 36(10). - P. 2275-2277.119120216. Samani N.J., Erdmann J., Hall A.S. et al. Genomewide association analysisof coronary artery disease // N. Engl. J. Med. - 2007. - Vol. 357(5).
- P. 443-453.217. Schelling P., Fischer H., Ganten D. Angiotensin and cell growth: a link tocardiovascular hypertrophy? // J. Hypertens. - 1991. - Vol. 9(1). - P. 3-15.218. Schneiderman J., Sawdey M.S., Keeton M.R. et al. Increased type Iplasminogen activator inhibitor gene expression in atherosclerotic human arteries //Proc.
Natl. Acad. Sci. USA. - 1992. - Vol. 89(15). - P. 6998-7002.219. Schulz U.G., Flossmann E., Rothwell P.M. Heritability of ischemic strokein relation to age, vascular risk factors, and subtypes of incident stroke in populationbased studies // Stroke. - 2004. - Vol.35 (4). - P. 819–824.220. Sirgo G., Perez-Vela J.L., Morales P. et al. Association between 4G/5Gpolymorphism of the plasminogen activator inhibitor 1 gene with stroke orencephalopathy after cardiac surgery // Intensive Care Med.
- 2006. - Vol. 32(5). - P.668-675.221.Slooter A.J., Rosendaal F.R., Tanis B.C. et al. Prothrombotic conditions,oral contraceptives, and the risk of ischemic stroke // J. Thromb. Haemost. - 2005. Vol. 3(6). - P. 1213-1217.222. Slowik A., Turaj W., Dziedzic T. DD genotype of ACE gene is a risk factorfor intracerebral hemorrhage // Neurology. - 2004. - Vol. 63(2). - P. 359-361.223.Song Q., Cole J.W., O'Connell J.R.
et al. Phosphodiesterase 4Dpolymorphisms and the risk of cerebral infarction in a biracial population: the StrokePrevention in Young Women Study // Hum. Mol. Genet. - 2006. - Vol. 15(16). - P.2468-2478.224.Sonoda A., Murata M., Ikeda Y. et al. Stroke and platelet glycoprotein Ibapolymorphisms // Thromb. Haemost. - 2001. - Vol. 85(3). - P. 573-574.225.Sonoda A., Murata M., Ito D. et al.
Association between plateletglycoprotein Ibalpha genotype and ischemic cerebrovascular disease // Stroke. - 2000. Vol. 31(2). - P. 493-197.226. Spanbroek R., Grabner R., Lotzer K. et al. Expanding expression of the5lipoxygenase pathway within the arterial wall during human atherogenesis // Proc.Natl. Acad. Sci. USA. - 2003.
- Vol. 100(3). - P. 1238-1243.120121227.Staton J.M., Sayer M.S., Hankey G.J. et al. Association betweenphosphodiesterase 4D gene and ischaemic stroke // J. Neurol. Neurosurg. Psychiatry. 2006. - Vol. 77(9). - P. 1067-1069.228. Szolnoki Z., Havasi V., Bene J. et al. Endothelial nitric oxide synthase geneinteractions and the risk of ischaemic stroke // Acta Neurol. Scand. - 2005. - Vol.111(1). - P. 29-33.229. Szolnoki Z., Somogyvari F., Kondacs A.
et al. Evaluation of the modifyingeffects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke// J. Neurol. Neurosurg. Psychiatry. - 2003. - Vol. 74(12). - P. 1615-1620.230.Szolnoki Z., Somogyvari F., Kondacs A. et al. Evaluation of the roles ofthe Leiden V mutation and ACE I/D polymorphism in subtypes of ischaemic stroke // J.Neurol.
- 2001. - Vol. 248(9). - P. 756-761.231.Szpirer C., Szpirer J., Riviere M. et al. Chromosomal localization of thehuman and rat genes (PDE4D and PDE4B) encoding the cAMP specificphosphodiesterases 3 and 4 // Cytogenet. Cell Genet. - 1995. - Vol. 69(1-2). - P. 11-14.232. Tham W. et al. Progression of cognitive impairment after stroke : one yearresults from a longitudinal study of Singaporean stroke patients.
J. Neurol. Sci. - 2002. Vol. 203/204. - P. 49-52.233. Thorelli E., Kaufman R.J., Dahlback B. The C-terminal region of the factorV B-domain is crucial for the anticoagulant activity of factor V // J. Biol. Chem. - 1998.- Vol. 273(26). - P.16140-16145.234.Thun M.J., Apicella L.F., Henley S.J. Smoking vs other risk factors as thecause of smoking-attributable deaths: confounding in the courtroom // JAMA. - 2000. Vol. 284(6). - P. 706 -712.235.Tiret L., Rigat B., Visvikis S. et al.
Evidence, from combined segregationand linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) genecontrols plasma ACE levels // Am. J. Hum. Genet. - 1992.- Vol. 51(1). - P. 197-205.236. Touboul P.J, Elbaz A., Koller C., et al. Common carotid artery intimamedia thickness and ischemic stroke subtypes: the GENIC casecontrol study. TheGENIC Investigators.
Circulation. - 2000. - Vol.102(3). - P.313–8.237. Touzé E., Rothwell P.M. Sex differences in heritability of ischemic stroke:a systematic review and meta-analysis // Stroke. - 2008. - Vol.39 (1). - P. 16–23.121122238.Tracy P.B., Eide L.L., Bowie E.J. Radioimmunoassay of factor V inhuman plasma and platelets // Blood. - 1982. - Vol. 60(1). - P. 59-63.239. Tsantes A.E., Nikolopoulos G.K., Bagos P.G., Bonovas S.,Kopterides P.,VaiopoulosG.Theeffectoftheplasminogenactivatorinhibitor_14G/5Gpolymorphismon the thrombotic risk // Thromb.
- 2008. - P. 736–742.240. Varadi K., Rosing J., Tans G. et al. Factor V enhances the cofactor functionof protein S in the APC-mediated inactivation of factor VIII: influence of the factorVR506Q mutation // Thromb. Haemost. - 1996. - Vol. 76(2). - P. 208-214.241. Voetsch B, Benke KS, Panhuysen CI, Damasceno BP, Loscalzo J.Thecombined effect of paraoxonase promoter and coding region polymorphisms on the riskof arterial ischemic stroke among young adults // Arch Neurol. - 2004.
- Vol. 61(3). - P.351-356.242. Walker S.P., Rimm E.B., Ascherio A. Body size and fat distribution aspredictors of stroke among US men // Am. J. Epidemiol. - 1996. - Vol. 144(12). - P.1143-1150.243. Whisnant J.P. Modeling of risk factors for ischemic stroke. The WillisLecture // Stroke. - 1997. - Vol. 28 (9). - P. 1840–1844.244.Wiklund P.G., Nilsson L., Ardnor S.N. et al. Plasminogen activatorinhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nestedcase-control studies based on independent cohorts // Stroke. - 2005.
- Vol. 36(8). - P.1661-1665.245. Wolf P. A., D'Agostino R.B., Belanger A. J., Kannel W.B. Probability ofstroke: a risk profile from the Framingham Study // Stroke. - 1991. - Vol. 22(3). - P.312-318.246.Wolfe C.D.A., Rudd A.G., Howard R. et al. The incidence and case fatilityof stroke subtypes in a multi ethnic population. The South London Stroke Register //Journal of Neurology Neurosurgery and Psychiatry. - 2002. - Vol. 72(2). - P. 211-216.247.Woo D., Kaushal R., Kissela B.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
